P Marriott - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P Marriott

Showing results (61-70 of 67) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 67 results.

CNS Drugs|April 13, 2021

Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort StudyNabil Seery, Sifat Sharmin, Vivien Li, et al.

Glia|February 3, 2015

Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factorMelissa M Gresle, Helmut Butzkueven, Victoria M Perreau, et al.

Multiple Sclerosis and Related Disorders|February 26, 2022

Response to treatment in NMOSD: the Australasian experienceLaura Clarke, Wajih Bukhari, Cullen M O'Gorman, et al.

Journal of Neurology|February 2, 2020

The clinical profile of NMOSD in Australia and New ZealandWajih Bukhari, Laura Clarke, Cullen O'Gorman, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|May 28, 2017

Incidence and prevalence of NMOSD in Australia and New ZealandWajih Bukhari, Kerri M Prain, Patrick Waters, et al.

Frontiers in Neurology|July 3, 2020

Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal VariationElham Khalilidehkordi, Laura Clarke, Simon Arnett, et al.

Frontiers in Neurology|September 27, 2021

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple SclerosisLaura Clarke, Simon Arnett, Wajih Bukhari, et al.

Pageof 7

Search research articles

Showing results (61-70 of 67) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 67 results.

CNS Drugs|April 13, 2021

Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort StudyNabil Seery, Sifat Sharmin, Vivien Li, et al.

Glia|February 3, 2015

Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factorMelissa M Gresle, Helmut Butzkueven, Victoria M Perreau, et al.

Multiple Sclerosis and Related Disorders|February 26, 2022

Response to treatment in NMOSD: the Australasian experienceLaura Clarke, Wajih Bukhari, Cullen M O'Gorman, et al.

Journal of Neurology|February 2, 2020

The clinical profile of NMOSD in Australia and New ZealandWajih Bukhari, Laura Clarke, Cullen O'Gorman, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|May 28, 2017

Incidence and prevalence of NMOSD in Australia and New ZealandWajih Bukhari, Kerri M Prain, Patrick Waters, et al.

Frontiers in Neurology|July 3, 2020

Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal VariationElham Khalilidehkordi, Laura Clarke, Simon Arnett, et al.

Frontiers in Neurology|September 27, 2021

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple SclerosisLaura Clarke, Simon Arnett, Wajih Bukhari, et al.

Pageof 7